Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …
Escherichia coli: an old friend with new tidings
J Vila, E Sáez-López, JR Johnson… - FEMS microbiology …, 2016 - academic.oup.com
Escherichia coli is one of the most-studied microorganisms worldwide but its characteristics
are continually changing. Extraintestinal E. coli infections, such as urinary tract infections …
are continually changing. Extraintestinal E. coli infections, such as urinary tract infections …
Biofilm infections, their resilience to therapy and innovative treatment strategies
U Römling, C Balsalobre - Journal of internal medicine, 2012 - Wiley Online Library
Biofilm formation of microorganisms causes persistent tissue and foreign body infections
resistant to treatment with antimicrobial agents. Up to 80% of human bacterial infections are …
resistant to treatment with antimicrobial agents. Up to 80% of human bacterial infections are …
Cyclic di-GMP: the first 25 years of a universal bacterial second messenger
U Römling, MY Galperin… - … and Molecular Biology …, 2013 - Am Soc Microbiol
Twenty-five years have passed since the discovery of cyclic dimeric (3′→ 5′) GMP (cyclic
di-GMP or c-di-GMP). From the relative obscurity of an allosteric activator of a bacterial …
di-GMP or c-di-GMP). From the relative obscurity of an allosteric activator of a bacterial …
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
MC Hanson, MP Crespo, W Abraham… - The Journal of …, 2015 - Am Soc Clin Investig
Cyclic dinucleotides (CDNs) are agonists of stimulator of IFN genes (STING) and have
potential as vaccine adjuvants. However, cyclic di-GMP (cdGMP) injected sc shows minimal …
potential as vaccine adjuvants. However, cyclic di-GMP (cdGMP) injected sc shows minimal …
Newly described pattern recognition receptors team up against intracellular pathogens
P Broz, DM Monack - Nature Reviews Immunology, 2013 - nature.com
Recognizing the presence of invading pathogens is key to mounting an effective innate
immune response. Mammalian cells express different classes of germline-encoded pattern …
immune response. Mammalian cells express different classes of germline-encoded pattern …
Better adjuvants for better vaccines: Progress in adjuvant delivery systems, modifications, and adjuvant–antigen codelivery
ZB Wang, J Xu - Vaccines, 2020 - mdpi.com
Traditional aluminum adjuvants can trigger strong humoral immunity but weak cellular
immunity, limiting their application in some vaccines. Currently, various immunomodulators …
immunity, limiting their application in some vaccines. Currently, various immunomodulators …
Antibiotics in Canadian poultry productions and anticipated alternatives
MS Diarra, F Malouin - Frontiers in microbiology, 2014 - frontiersin.org
The use of antibiotics in food-producing animals has significantly increased animal health by
lowering mortality and the incidence of diseases. Antibiotics also have largely contributed to …
lowering mortality and the incidence of diseases. Antibiotics also have largely contributed to …
Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP,(p) ppGpp signaling in bacteria and implications in pathogenesis
For an organism to survive, it must be able to sense its environment and regulate
physiological processes accordingly. Understanding how bacteria integrate signals from …
physiological processes accordingly. Understanding how bacteria integrate signals from …
STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment
T Ohkuri, A Ghosh, A Kosaka, J Zhu, M Ikeura… - Cancer immunology …, 2014 - AACR
Although type I IFNs play critical roles in antiviral and antitumor activity, it remains to be
elucidated how type I IFNs are produced in sterile conditions of the tumor microenvironment …
elucidated how type I IFNs are produced in sterile conditions of the tumor microenvironment …